Grey Wolf Therapeutics
2 clinical trials · Sponsor
◉ Watch Grey Wolf Therapeutics
| Record | Firm | Date |
|---|---|---|
| EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1) (NCT07047703) | Grey Wolf Therapeutics | 2025-07-28 |
| EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) (NCT06923761) | Grey Wolf Therapeutics | 2023-05-21 |
Track Grey Wolf Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.